Back

Generic apixaban: how should we buy it at the hospital level?

13 May 2024 (09:00 - 10:36)
Organised by: Logo
Congress Presentation Part of: ePosters in e-Cardiology/digital health 1 m-Health & Mobile Apps HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ines Miranda

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

4 More presentations in this session

Presentation thumbnail
Small changes can make a difference: the impact of different ajmaline challenge protocols on carbon footprint
Doctor C. Oliveira (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Barriers and solutions for deploying, expanding and sustaining remote patient monitoring for managing patients with heart failure: qualitative questionnaire-based study in France
Doctor M. EL BLIDI (Le Kremlin-Bicetre, FR)
Abstract Slides Video
Presentation thumbnail
Smart technology to enable remote patient monitoring in Heart failure patients (STAR - HF) - Proof of concept study
Doctor A. Soliman (Dammam, SA)
Abstract Slides Video
Presentation thumbnail
Patients with hypertension or chronic kidney disease demonstrated reduced diurnal variation in advanced hemodynamic parameters
Doctor D. Nachman (Jerusalem, IL)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in e-Cardiology/digital health 1

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
The first year of generic NOACs: implications for patients and the healthcare system
thumbnail
Congress Presentation
Cost differences between oral anticoagulation therapies in atrial fibrillation patients
thumbnail
Congress Presentation
Cost-effectiveness of apixaban vs aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources